March 6th, 2007, by Digital Davo | seborrheic dermatitis
Although this poster session doesn’t name Xolegel (poster sessions aren’t supposed to name products directly) as the product that was studied, it looks likely that this is the product as the company involved, Barrier Therapeutics has recently gained FDA approval for Xolegel (also known as sebazole).Anti-inflammatory effects of ketoconazole: Clinical benefits in the treatment of seborrheic dermatitis, Lieve Vandeplassche, Barrier Therapeutics, Princeton, NJ, United StatesSeborrheic …
February 23rd, 2007, by Digital Davo | seborrheic dermatitis
The study below is targetting a new cleansing method for those who suffer from seborrheic dermatitis. SD is associated with an excess of sebum which may lead to irritation. A sonic cleanser that is gentle enough for those who also suffer from rosacea could be a useful addition to a cleansing routine.
Firstly some background on …
March 20th, 2006, by Digital Davo | seborrheic dermatitis
An open-label study to evaluate the systemic absorption of ketoconazole in subjects applying ketoconazole USP 2% topical gel for the treatment of seborrheic dermatitisVera Van de Velde, PhD, Princeton, NJ, United States; Charles Barranco, Brian Beger, Barrier Therapeutics, Princeton, NJ, United StatesMethods: The systemic absorption of ketoconazole from ketoconazole USP 2% topical gel was evaluated in subjects with severe seborrheic dermatitis …
March 10th, 2006, by Digital Davo | seborrheic dermatitis
A 52-week open label study of the safety of ketoconazole USP 2% topical gel in the treatment of seborrheic dermatitisBrian Beger, Newtown, PA, United States; Charles Barranco, Geert Cauwenbergh, PhD, Barrier Therapeutics, Princeton, NJ, United StatesIntroduction: Seborrheic dermatitis is a common inflammatory scaling disease affecting areas of the skin with sebaceous glands. Seborrheic dermatitis may appear in infancy but is not …
January 27th, 2006, by Digital Davo | seborrheic dermatitis
The author is warning that as seborrheic dermatitis is not well understood and although some studies are showing that pimecrolimus and tacrolimus can be effective, some caution is still advised until large studies are completed.Pharmacotherapy Update: Treating Seborrheic Dermatitis, James Q. Del Rosso, D.O., F.A.O.C.D.Journal: Skin & Aging, Issue Number: 2, 2005Seborrheic dermatitis is a common inflammatory chronic-recurrent …
|
|
|
|
|
|
|
|
|